Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma [Phase 4]
A Phase 4 trial evaluating omalizumab in adults and adolescents with severe persistent allergic asthma has completed, with results posted in…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Utilization of Fixed Combination (Budesonide/Formoterol and Salmeterol/Fluticasone and Beclomethasone/Formoterol) in Treatment of Asthma Patients
An update on a completed clinical trial evaluating the use of fixed-dose inhaled corticosteroid/long-acting beta-agonist combinations in ast…
-
CLINICAL_TRIALS research · 2011-07-22Clinical Trial Update: Standardisation of Measurements in Exhaled Breath and Exhaled Breath Condensate.
A clinical trial update about standardising measurements in exhaled breath and exhaled breath condensate, led by Maastricht University Medic…
-
CLINICAL_TRIALS trial_result · 2011-07-20Clinical Trial Update: Relative Potency of Inhaled Corticosteroids [Phase 4]
Phase 4 trial update evaluating the relative potency of inhaled corticosteroids in asthma and chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS research · 2011-07-20Clinical Trial Update: Retrospective Study for Description of The Use Of Omalizumab In Patients With Difficult To Control Asthma
A retrospective study describing how omalizumab has been used in patients with difficult-to-control asthma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-20Clinical Trial Update: Clinical Trial to Assess Efficacy, Safety, Treatment Adherence and Quality of Life Impact of Mometasone Furoate in Asthmatic Patients (Study P04879)(TERMINATED) [Phase 4]
A Phase 4 trial evaluating the efficacy, safety, treatment adherence and quality of life impact of mometasone furoate in asthmatic patients …
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma [Phase 2]
Phase 2 trial evaluating the clinical and biological effects of omalizumab in patients with bilateral nasal polyposis and asthma has complet…
-
CLINICAL_TRIALS research · 2011-07-08Clinical Trial Update: Asthma Learning Project [NA]
A clinical trial update for an asthma study sponsored by Seattle Children's Hospital; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2011-06-28Clinical Trial Update: To Investigate the Effects of AZD1981 on the QT Interval [Phase 1]
This clinical trials update notes the completion of a Phase 1 study assessing the effect of AZD1981 on the QT interval in individuals with a…
-
FDA approval · 2011-06-27FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Advair HFA (fluticasone propionate and salmeterol xinafoate) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2011-06-27FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Advair Diskus (fluticasone propionate and salmeterol) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2011-06-27FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for SEREVENT DISKUS (salmeterol xinafoate) filed by GlaxoSmithKline LLC. This action updates the…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Demonstration of Broncholytic Effects in Subjects With Obstructive Airway Diseases by Low Frequency Ultrasound [NA]
The trial update reports broncholytic effects of low-frequency ultrasound in subjects with obstructive airway diseases, including COPD and a…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Safety and Efficacy Study of the Use of Sodium Pyruvate Bronchodilation in Asthmatics [Phase 1, Phase 2]
This update reports a Phase 1/2 safety and efficacy trial of a sodium pyruvate bronchodilator for moderate asthma, which has been terminated…
-
FDA approval · 2011-06-23FDA Approved: BUDESONIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for budesonide from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma [Phase 3]
Phase 3 trial comparing the new combination inhaler FlutiForm HFA MDI 100/10 µg versus fluticasone and formoterol given separately, and plac…
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma [Phase 3]
A Phase 3 trial evaluated a new combination inhaler, FlutiForm HFA at two dose strengths (100/10 µg and 250/10 µg), against fluticasone prop…
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma [Phase 3]
Phase 3 trial comparing the new inhaler FlutiForm HFA MDI 100/10 µg against standard fluticasone/formoterol in asthma patients has completed…
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients [Phase 2]
A completed Phase 2 single-dose crossover trial evaluated the safety and efficacy of FlutiForm compared with Fluticasone + Formoterol given …
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005 [Phase 3]
Phase 3 open-label continuation study in moderate-to-severe asthma patients who completed the SKY2028-3-005 trial of FlutiForm HFA inhalatio…
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma. [Phase 3]
A Phase 3 trial evaluated whether twice-daily rabeprazole improves asthma control in subjects with asthma, with GERD as a co-occurring condi…
-
CLINICAL_TRIALS research · 2011-06-16Clinical Trial Update: Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma
This is a completed observational and epidemiologic study led by Novartis to understand the disease course and unmet needs in children with …
-
FDA approval · 2011-06-10FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved Organon LLC's supplemental application for Singulair (montelukast sodium), granting approval of the requested supplemental acti…
-
FDA label_change · 2011-06-10FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) submitted by Organon LLC, likely affecting labeling and/or indications.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers [Phase 1]
A Phase 1 pharmacokinetic pilot study evaluating budesonide/formoterol delivered via a device-metered dry powder inhaler has completed.